RESUMO
ABSTRACT: Objective: To compare the use of drugs to control low back pain in the pre- and postoperative periods among patients with Failed Back Surgery Syndrome (FBSS) undergoing neuromodulation. Methods: Retrospective observational study analyzing the medical records of patients with FBSS who underwent neuromodulation, followed up in an outpatient clinic from 2018 to 2020. The characteristics of the patients were evaluated: the use of medications, quality of life through the results of the Short Form 36 Health Survey Questionnaire (SF-36), and functional capacity using the Oswestry Disability Index (ODI) in the pre-surgical and post-surgical periods (06 months, 01 year). The criterion for establishing statistical significance was p≤0.05. Results: 56 patients were evaluated. There was a reduction in the use of pain control drugs after the institution of neuromodulation, including in the opioid class (d=0.81). An improvement was also observed in the ODI scores (p<0.001) and all the SF-36 domains (p<0.02) in the postoperative periods investigated. Conclusion: The data suggest that neuromodulation positively impacted back pain by reducing medication use and improving functional capacity and quality of life. Level of Evidence IV; Retrospective, Observational Study.
RESUMO: Objetivo: Comparar o uso de medicamentos para o controle da dor lombar nos períodos pré e pós-operatórios entre pacientes com Síndrome da Falha da Cirurgia na Coluna (FBSS) submetidos à neuromodulação. Métodos: Estudo observacional retrospectivo de análise de prontuários dos pacientes com FBSS submetidos à neuromodulação, acompanhados ambulatorialmente no período de 2018 a 2020. Foram avaliadas as características dos pacientes; o uso de medicamentos; a qualidade de vida através dos resultados do Questionário Short Form 36 Health Survey Questionnaire (SF- 36) e a capacidade funcional utilizando o Oswestry Disability Index (ODI) nos períodos pré-cirúrgico e pós-cirúrgicos (06 meses, 01 ano). O critério para estabelecer significância estatística foi valores de p≤0,05. Resultados: Foram avaliados 56 pacientes. Verificou-se redução do uso de medicamentos para o controle da dor após a instituição da neuromodulação, inclusive na classe dos opioides (d=0,81). Observou-se ainda melhora nos escores do ODI (p<0,001) e de todos os domínios do SF-36 (p<0,02) nos períodos pós-operatórios investigados. Conclusão: Os dados sugerem que a neuromodulação teve impacto positivo na dor de coluna em termos de redução no uso de medicamentos, melhora da capacidade funcional e da qualidade de vida. Nível de Evidência IV; Estudo Retrospectivo, Observacional.
RESUMEN: Objetivo: Comparar el uso de fármacos para el control de la lumbalgia en el pre y posoperatorio en pacientes con Síndrome de Cirugía Fallida de Columna (FBSS) sometidos a neuromodulación. Métodos: Estudio observacional retrospectivo analizando las historias clínicas de pacientes con FBSS que se sometieron a neuromodulación, seguidos en consulta externa de 2018 a 2020. Se evaluaron las características de los pacientes; el uso de medicamentos; calidad de vida a través de los resultados del Cuestionario Short Form 36 Health Survey Questionnaire (SF-36) y la capacidad funcional mediante el Oswestry Disability Index (ODI) en los períodos prequirúrgico y posquirúrgico (06 meses, 01 año). El criterio para establecer la significación estadística fue p≤0,05. Resultados: se evaluaron 56 pacientes. Hubo una reducción en el uso de medicamentos para el control del dolor después de la institución de la neuromodulación, incluso en la clase de opioides (d = 0,81). También se observó una mejora en las puntuaciones del ODI (p<0,001) y en todos los dominios del SF-36 (p<0,02) en los períodos postoperatorios investigados. Conclusión: Los datos sugieren que la neuromodulación tuvo un impacto positivo en el dolor de espalda en términos de reducción del uso de medicamentos, mejorando la capacidad funcional y la calidad de vida. Nivel de Evidencia IV; Estudio Retrospectivo, Observacional.
Assuntos
Coluna VertebralRESUMO
INTRODUCTION: Non-operative treatment is an exceptional indication for the treatment of proximal femur fracture. The aim of the study was to analyze the mortality rate in one year and associated factors in severely ill patients submitted to non-operative treatment. METHODS: It was included 28 patients treated from August 2014 to September 2019. Eighteen (64.3%) patients were female and 10 (35.7%) were male. The mean age was 78.7 ± 11.9 years old. The main outcome evaluated was the mortality rate in one year. It was also evaluated the correlation with gender, age, personal habits, number of comorbidities and Charlson Comorbidity Index (CCI). RESULTS: The functional result was assessed with WOMAC score via telephone call. The mortality rate in one year was 42.8% without statistical positive correlation with any of the studied parameters. Patients with three or more comorbidities didn't have a higher mortality rate comparing to survived patients (83.3% vs 81.3%). The CCI also didn't show any correlation with high mortality (6.9 vs 7.1). The functional result of the survived patients was poor (78.2 points WOMAC). CONCLUSION: The conclusion is that the mortality rate in one year of ill patients with hip fractures treated non-operatively is 42.8% without correlation with age, gender of number of comorbidities, and the functional result of the survived patients is poor.